CARE Ratings Intrinsic Value
CARE Ratings (CARERATING) median intrinsic value is ₹628.67 from 10 valuation models (range ₹336–₹1152), vs current price ₹1680.00 — -62.6% downside (Trading Above Calculated Value), margin of safety -100.0%. Analyse CARE Ratings ownership structure to track promoter, FII and institutional holdings.
CARERATING Valuation Methods Summary — DCF, Graham Number & P/E
CARE Ratings intrinsic value across 10 models vs current price ₹1680.00 — upside/downside and value range per method. Read CARERATING ex-dividend dates for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹843.84 | ₹675.07 - ₹1012.61 | -49.8% | EPS: ₹70.32, Sector P/E: 12x |
| Book Value Method | asset | ₹336.00 | ₹302.40 - ₹369.60 | -80.0% | Book Value/Share: ₹314.33, P/B: 0.8x |
| Revenue Multiple Method | revenue | ₹504.00 | ₹453.60 - ₹554.40 | -70.0% | Revenue/Share: ₹194.67, P/S: 1.0x |
| EBITDA Multiple Method | earnings | ₹672.00 | ₹604.80 - ₹739.20 | -60.0% | EBITDA: ₹308.00Cr, EV/EBITDA: 5x |
| Simple DCF (5Y) | dcf | ₹672.00 | ₹537.60 - ₹806.40 | -60.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹504.00 | ₹453.60 - ₹554.40 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹579.44 | ₹521.50 - ₹637.38 | -65.5% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹1152.00 | ₹1036.80 - ₹1267.20 | -31.4% | ROE: 22.9%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹628.67 | ₹565.80 - ₹691.54 | -62.6% | EPS: ₹70.32, BVPS: ₹314.33 |
| Dividend Yield Method | dividend | ₹550.00 | ₹495.00 - ₹605.00 | -67.3% | DPS: ₹22.00, Target Yield: 4.0% |
CARERATING Intrinsic Value vs Market Price — All Valuation Models
CARE Ratings fair value range ₹336–₹1152 vs current market price ₹1680.00 across 10 valuation models. For current market price and key ratios, visit CARERATING screener.
CARERATING Intrinsic Value Analysis — Undervalued or Overvalued?
CARE Ratings median intrinsic value ₹628.67, current price ₹1680.00 — Trading Above Calculated Value by 62.6%, margin of safety -100.0%.
What is the intrinsic value of CARERATING?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of CARE Ratings (CARERATING) is ₹628.67 (median value). With the current market price of ₹1680.00, this represents a -62.6% variance from our estimated fair value.
The valuation range spans from ₹336.00 to ₹1152.00, indicating ₹336.00 - ₹1152.00.
Is CARERATING undervalued or overvalued?
Based on our multi-method analysis, CARE Ratings (CARERATING) appears to be trading above calculated value by approximately 62.6%.
CARERATING Financial Health — Key Ratios vs Industry Benchmarks
CARE Ratings financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 15.39 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 22.9% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 46.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.53x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
CARERATING Cash Flow Quality — Operating & Free Cash Flow
CARE Ratings operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹148 Cr | ₹101 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹123 Cr | ₹94 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹91 Cr | ₹72 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹82 Cr | ₹82 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹68 Cr | ₹55 Cr | Positive Free Cash Flow | 8/10 |